Oxaliplatin Medac 100mg Powder for Solution for Infusion is an essential chemotherapeutic agent used in the treatment of various cancers. This medication, from the trusted manufacturer MEDAC, is formulated as a powder that is reconstituted to create a solution for intravenous infusion. It is indicated for use under strict medical supervision as part of a comprehensive cancer treatment regimen.

Oxaliplatin Medac 100mg provides targeted action against cancer cells, playing a crucial role in oncology treatment.

It is primarily used in the treatment of advanced colorectal cancer, often in combination with fluoropyrimidines.

May also be indicated for adjuvant treatment of stage III colon cancer after complete resection of the primary tumor.

Effective in improving progression-free survival and overall survival rates in suitable patients.

Oxaliplatin Medac 100mg is a potent chemotherapeutic agent that must be prepared and administered by qualified healthcare professionals.

1. The powder is reconstituted using an appropriate diluent, typically Water for Injections or 5% Glucose solution, to form a concentrate.
2. The concentrate is then further diluted with 250 to 500 mL of 5% Glucose solution for infusion.
3. Administer as an intravenous infusion over 2 to 6 hours.
4. The dose and frequency of administration are determined by the treating physician based on the patient's condition, body surface area, and the specific cancer protocol being followed.
5. Ensure careful monitoring of the patient throughout the infusion and post-infusion period for any adverse reactions.

Due to the nature of this medication, several precautions and warnings must be strictly observed:

• Must be administered under the supervision of a physician experienced in antineoplastic chemotherapy.
• Monitor for signs of peripheral neuropathy, which can be irreversible.
• Regular complete blood counts are required due to potential myelosuppression (decreased bone marrow activity).
• Patients should be monitored for nausea, vomiting, diarrhea, and mucositis, which are common side effects.
• Assess liver function and kidney function before and during treatment.
• Avoid use during pregnancy and breastfeeding; effective contraception is advised for both male and female patients during and after treatment.
• Hypersensitivity reactions, including anaphylaxis, may occur and require immediate medical intervention.
• Extravasation should be avoided; if it occurs, appropriate local treatment should be initiated immediately.

Active Ingredient:

• Oxaliplatin 100mg

Excipients:

• Typically, sterile powders for solution for infusion like Oxaliplatin may contain minimal or no additional excipients beyond the active substance itself to ensure purity and stability. Refer to the product's official package leaflet for precise excipient information.

Strength: 100mg

Dosage Form: Powder for solution for infusion

Packaging: Vial

Manufacturer: MEDAC GmbH

Drug Type: Prescription Antineoplastic Agent